Safety and Effectiveness of Edoxaban in Japanese Venous Thromboembolism Patients: Final Analysis of 1Y Follow-up Data From a Japanese Postmarketing Observational Study (ETNA-VTE-Japan)
https://t.co/kAiIMoWpQl
#Edoxaban 1yr f/u
#VTE
30mgと60㎎の適正使用患者での効果安全性は同等 https://t.co/Gn8mwa0GHz
Changes in aortic stiffness after exercise were associated with exercise tolerance in patients at risk of heart failure (HF). This may be useful to risk stratify stage A and B HF.
By Tatsuya Mizoguchi @ncu_cardiology
https://t.co/FBbMzhrDnT
#circ_j https://t.co/srchuyaMRi
I made an educational lecture about "Takotsubo syndrome" during the 25th Annual Scientific Meeting of the Japanese Heart Failure Society. This is the paper that my great mentor, Dr. Iga, gave to me more than 30 years ago. https://t.co/NWnuv7HzyU https://t.co/WlvHvcawkg
In #Japan, improving the prognosis & quality of life of patients, as well as improving the healthcare system, requires comprehensive information.
The Cardiovascular Intervention and Therapeutics (CVIT) nationwide registry.
@JCIRC_IPR
Our #REALITYAHF substudy has been published in #circ_j.
Percent heart rate reduction was associated with better short-term prognosis in patients with acute heart failure presenting with AF, particularly those with rapid ventricular response.
https://t.co/iDs5OA5YNc https://t.co/3syFTn6Eev
Long-term use of PCSK9 inhibitor evolocumab robustly lowers LDL-C and is equally efficacious in lowering the risk of cardiovascular events and safe in Asians as it is in non-Asians.
By Kazuma Oyama @KazumaOyama
https://t.co/3rM44uVlFa
#circ_j https://t.co/FgCskCQIhH
Tweet the meeting!! https://t.co/7VhVorpNe4
Visualized network of #21JCS and evaluated the effectiveness of JCS Official Twitter ambassodors.
@JeffLienert @tkishi_cardiol @8TqVAR24G6B1c5v @memori_fukuda @CircChi @tadafumisugimo1 @Yuki_Sahashi @zIBBIfhjkhpr9hF https://t.co/cEPL3vUH90
We are very pleased that our paper has been published in the International Heart Journal.
J-STAGE Articles - Serial Changes in Cardiac Strain and Contractility After Hematopoietic Stem Cell Transplantation in Patients with Hematologic Malignancies https://t.co/1bf9PBb6gN
J-STAGE Articles - Clinical and Biomarker Profiles and Prognosis of Elderly Patients With Coronavirus Disease 2019 (COVID-19) With Cardiovascular Diseases and/or Risk Factors https://t.co/BdEH6UxUcJ
Check them out !!
The restriction policies in Cardiology departments in JAPAN during COVID-19 pandemic last year.
1st nationwide survey (April 2020)
https://t.co/OKcnKm40VN
2nd nationwide survey (August 2020)
https://t.co/xD9src7Nxs
#Cardiology #cardiotwitterJapan #COVID
Check them out !!
The restriction policies in Cardiology departments in JAPAN during COVID-19 pandemic last year.
1st nationwide survey (April 2020)
https://t.co/OKcnKm40VN
2nd nationwide survey (August 2020)
https://t.co/xD9src7Nxs
#Cardiology #cardiotwitterJapan #COVID
J-STAGE Articles - Japanese Heart Failure Society 2018 Scientific Statement on Nutritional Assessment and Management in Heart Failure Patients https://t.co/5pDBAMpRBf
From Circulation Reports.
First study reporting the safety and effectiveness of edoxaban in Japanese patients with VTE in a long-term treatment in a real-world setting.
https://t.co/gl04VcUp9N
CR Editor K
#circ_rep https://t.co/VBvNmfN03a
Check it NOW !!
#JCS @JCIRC_IPR 2017/ JHFS 2017 #Guideline on Diagnosis and Treatment of Acute and Chronic Heart Failure
#circ_j
#CardioTwitter #CardioJapan @American_Heart @ACCinTouch @escardio
https://t.co/5nnZeHStii
by information & Communication Committee K
ついに日本の心不全ガイドラインの英語版が!これで英語論文でも引用できますね。#CardioJapan JCS 2017/JHFS 2017 Guideline on Diagnosis and Treatment of Acute and Chronic Heart Failure ― Digest Version ― https://t.co/clikQkF0PJ